Open Preliminary Randomized Prospective Clinical Trial of Efficacy and Safety of Three Different Verapamil Dilutions for Intraplaque Therapy of Peyronie's Disease

Urology

Volumn 69, Issue 5, 2007, Pages 950-954

  Cavallini, Giorgio ^a   Modenini, Fabio ^a   Vitali, Giovanni ^a  

^a Laboratory of Assisted Reproduction   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ECCHYMOSIS; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; PAIN; PEYRONIE DISEASE; PRIORITY JOURNAL;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PENILE INDURATION; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VASODILATOR AGENTS; VERAPAMIL;

EID: 34247559663     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.080     Document Type: Article

References (19)

1. Mulhall J.P., Schiff J., and Guhring P. An analysis of the natural history of Peyronie's disease. J Urol 175 (2006) 2115-2118
2. Gustafson H., Johansson B., and Edsmyr F. Peyronie's disease: experience with local treatment with orgotein. Eur Urol 7 (1981) 246-248
3. Taranger L.A., Robson C.J., and Barkin M. The surgical approach to Peyronie's disease. J Urol 114 (1975) 404-409
4. Levine L.A., Goldman K., and Greenfield J.M. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 168 (2002) 621-626
5. Dang G., Matern R., Bivilacqua T.J., et al. Intralesional interferon-alpha-2b injections for the treatment of Peyronie's disease. South Med J 97 (2004) 42-46
6. Gelbart M.K., James K., Riach P., et al. Collagenase versus placebo in the treatment of Peyronie's disease. J Urol 143 (1993) 2003-2005
7. Rehman J., Benet A., and Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a single blind long-term study. Urology 51 (1998) 620-626
8. Biagiotti G., and Cavallini G. Acetyl-l-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int 88 (2001) 61-63
9. Tefekli A., Kandirali E., Erol B., et al. Peyronie's disease: a silent consequence of diabetes mellitus. Asian J Androl 8 (2006) 75-77
10. Carson C., Kirby R., and Goldstein T. Textbook of Erectile Dysfunction (1999), Isis Medical Media, Oxford
11. Snedecor G.W., and Cochran W.G. Statistical Methods. 7th ed. (1987), Iowa State University Press, Ames, Iowa
12. Weidner W., Schroeder-Printzen I., Weiske W.H., et al. Sexual dysfunction in Peyronie's disease: an analysis of 222 patients without previous local plaque therapy. J Urol 157 (1997) 325-328
13. Bivalacqua T.J., Champion H.C., and Hellstrom W.J. Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. Int J Impot Res 14 (2002) 345-352
14. Iacono F., Barra S., De Rosa G., et al. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol 150 (1993) 1806-1809
15. Usta M.F., Bivalacqua T.J., Tokatli Z., et al. Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study. J Urol 172 (2004) 259-262
16. Hauck E.W., Mueller U.O., Bschleipfer T., et al. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials. J Urol 171 (2004) 740-745
17. Mulhall J.P., Martin D.J., Lubrano T., et al. Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model. Int J Impot Res 16 (2004) 99-104
18. Frati L. Le basi biologiche della terapia dei tumori. In: Pontieri G.M., Russo M.A., and Frati L. (Eds). Patologia Generale. 3rd ed. vol 1 (2004), Piccin Editore, Padova, Italy 855-873
19. Cavallini G. Towards an evidence based understanding of Peyronie's disease. Int J STD AIDS 16 (2005) 187-195